US Quantum Stocks Surge After $2 Billion Government Investment 
DOJ Investigates Group Linked to Reid Hoffman Over E. Jean Carroll Lawsuit Funding 
JPMorgan Sees Biotech Sector at Turning Point, Upgrades Top Pharma Stocks 
Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission 
Marvell Stock Rises After Record Q1 FY2027 Earnings Fueled by AI Demand 
NASA Faces Major Workforce Reduction as 20% of Employees Prepare to Leave 
Kentucky School District Secures $27 Million in Social Media Addiction Lawsuit Settlements 
Dollar Gains Slightly as U.S.-Iran Tensions Keep Forex Markets on Edge 
Trump Administration Releases New UFO Files and Apollo Mission Records 
Asian Currencies Steady as U.S.-Iran Ceasefire Extension Hopes Weigh on Dollar 
Iran-U.S. Nuclear Talks Remain Unresolved as Strait of Hormuz Risks Keep Markets on Edge 
South Korea Central Bank Holds Interest Rates Steady Amid Inflation Concerns 
U.S. Launches New Strikes on Iran as Trump Signals Peace Deal Uncertainty 
SpaceX’s Starship Completes 11th Test Flight, Paving Way for Moon and Mars Missions 
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026 
S&P 500, Nasdaq Hit Record Highs as Iran Ceasefire Talks and AI Rally Boost Markets 
Naver Cloud became the first South Korean cloud service provider to develop a gene data analysis platform.
The newly-developed Nvidia Clara Parabricks on the platform of Naver Cloud, an affiliate of South Korea’s leading internet portal operator Naver Corp., is the combination of the Naver Cloud server with US graphics chip giant Nvidia Corp.’s Clara Parabricks software suite.
Clara Parabricks is a system that uses huge graphic processing units to interpret gene data.
Naver Cloud plans to launch the Genome Analysis All-in-One Integrated Platform in its marketplace in the first half of this year, in conjunction with local personal genomics business ichrogene.
Beginning with the cooperation with Nvidia and ichrogene, Naver Cloud will continue to expand its presence in the gene analysis market, according to the company’s executive director, Han Sang-young.
